The first transformation of an existing Bulgarian capital company into a company with variable capital – a recently adopted by the legislator new form of company – is a already a fact. While the general expectations are that this new form of company is available for original incorporation and transformation is expected after these cease to be start-ups, it may be also appropriate for reshaping the business opportunities of already incorporated companies, eligible under the law. Our client Praeva Biotech, formerly wholly owned limited liability company, will continue to develop its business in the area of biotech innovations by making use of the advantages, provided for a company with variable capital. This project was completed primarily by Ina Raikova from Spasov & Bratanov.

 

Date: March 2025

Source: Spasov & Bratanov Lawyers’ Partnership 

 

More Posts

Spasov&Bratanov successful in the annulment by the court of a BGN 1 Million (circa EUR 511,000) GDPR Fine Our law firm has achieved a significant success in a challenge of an

Read More »

Mila Ivanova joins Spasov & Bratanov Spasov & Bratanov is pleased to announce that Mila Ivanova has joined the firm. Mila is a lawyer with over 10 years of professional

Read More »

Spasov & Bratanov Successful in Commercial Arbitration We are pleased to announce a significant victory on behalf of our client in a complex commercial arbitration proceedings against a foreign corporate

Read More »

Spasov & Bratanov has once again demonstrated its strong litigation capabilities and in-depth expertise in defending clients against asset confiscation claims initiated by the State, represented by the Commission for

Read More »

Share: